Polymorphic eruption of pregnancy successfully treated with dupilumab in the postpartum period: A case report
Alexa Moschella, Stephannie Dresden Glockler-Lauf, Niloufar Hosseini, Sophia Colantonio · 2026
Read Polymorphic eruption of pregnancy successfully treated with dupilumab in the postpartum period: A case report by Alexa Moschella, Stephannie Dresden Glockler-Lauf, Niloufar Hosseini, Sophia Colantonio (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13219878.txt.
Description
Alexa Moschella and co-authors report a pregnancy rash cleared by the antibody dupilumab after childbirth in a 2026 case report. Polymorphic eruption of pregnancy, an itchy rash of papules and plaques, strikes one in two hundred pregnancies, in the final month or after delivery. It fades within weeks, but the itch can be severe, and the rescue, oral steroids, was off the table for the patient.
The thirty-four-year-old mother developed the eruption two days after a caesarean delivery, with plaques across her abdomen, arms, legs, and feet. A biopsy excluded gestational pemphigoid. Because her gestational diabetes and hypertension ruled out prednisone, the team gave dupilumab, an antibody used in pregnancy and breastfeeding for other conditions, alongside a topical steroid and a roflumilast cream. By six weeks skin had cleared. The authors offer the case as evidence for a steroid-sparing option in severe disease.
Catalog record
| CREATOR | Alexa Moschella, Stephannie Dresden Glockler-Lauf, Niloufar Hosseini, Sophia Colantonio |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |